Correlation between protein abundances and R_5-20 z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... by Spela Kokelj (8356644)

<i>mMgat2</i> and <i>HuMgat2</i> mice exhibit a transcriptomic profile indicating impairments in metabolite detoxification and lipid metabolic processes. by J. Jose Corbalan (22439198)

Subjects:

Suggestive significant associations in the candidate gene approach. by Dai Nogimura (21445649)

Subjects:

Effects of allopurinol on PG-LPS-induced phospho-CaMKII by Akinaka Morii (12709672)

Subjects:

Patient flowchart. by Anna D. Ware (19688153)

Subjects:

Schematic illustration of the proposed role of XO and NOX4 in the heart of PG-LPS-treated mice. by Akinaka Morii (12709672)

Subjects:

Schematic illustration of experimental procedure and comparison by Akinaka Morii (12709672)

Subjects:

Kaplan-Meier survival analysis curves according to the APTT levels between four groups. by Huan Wang (109286)

Subjects:

Mean total cholesterol levels over time in the roxadustat group (A) and ESAs group (B) according to the statins subgroup. by Jie Liu (15128)

Forest plots of APTT for 28-day mortality in different subgroups. by Huan Wang (109286)

Subjects:

Kinetics of coagulation parameters between the survivors and non-survivors during hospitalization. by Huan Wang (109286)

Subjects:

Restricted cubic spline models depicting the relationship between APTT and mortality risk in SFTS. by Huan Wang (109286)

Subjects:

Normality test using the Shapiro-Wilk test. by Akinaka Morii (12709672)

Subjects:

Pneumococcal (black bars) and influenza (white bars) vaccine coverage in patients living with comorbidities (A), and immunosuppressive conditions (B) according to age of 65 years,... by Benjamin Wyplosz (22032756)

Subjects:

Pneumococcal (black bars) and influenza (white bars) vaccine coverage in patients living with comorbidities (A), and immunosuppressive conditions (B), who are at risk of pneumococc... by Benjamin Wyplosz (22032756)

Subjects:

Group control-after intervention. by Nan Tang (642590)

Subjects:

Group SFA-before intervention. by Nan Tang (642590)

Subjects:

Lost cases. by Nan Tang (642590)

Subjects:

Group control-before intervention. by Nan Tang (642590)

Subjects:

Patient satisfaction with SFA intervention(%). by Nan Tang (642590)

Subjects: